NervGen Announces First Participant Dosed in RESTORE, a Phase 3 Registrational Study Evaluating NVG-291 in Chronic Spinal Cord Injury
October 12, 2026
Eco Innovation Group Announces Patent Publication by USPTO Covering Glytech, LLC Supercritical Plant Extraction Technology
April 28, 2022
Related Post
-
-
X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures
October 8, 2026
-
Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology
October 8, 2026
-
MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer
October 7, 2026